$37.880
-1.617 (-4.27%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de SUPN por análisis de gráficos similares
Alphio's SUPN stock price prediction model matches the current Supernus Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $36.36 (-4.01%). The 1-week path is $35.78 (-5.54%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Supernus Pharmaceuticals Inc?
Supernus Pharmaceuticals Inc is currently not a strong buy due to significant recent losses and negative technical indicators. The current price is $37.88, and the stock has a 5-day change of -11.23%. Additionally, the RSI is extremely low at 13.38, indicating oversold conditions, but this also suggests potential for a rebound. However, the company reported a net loss exceeding $58 million in Q2 2026, contrasting sharply with a net income of $22.5 million in Q2 2025, highlighting ongoing financial struggles. The main risk is the insider selling, which increased by 2510.70% over the last month, signaling a lack of confidence among insiders. Therefore, while the stock may have potential long-term upside due to the merger with Indivior, the current financial and technical indicators suggest a hold position for now.
SUPN cerró en $37.88 el Friday, tras bajar -4.27%
Supernus Pharmaceuticals Inc (SUPN) last closed at $37.88, losing -4.27%. These facts feed the 1-day and 1-week SUPN price prediction above.
Consenso de analistas
Supernus Pharmaceuticals Inc (SUPN): 6 comprar, 2 mantener, 0 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Supernus Pharmaceuticals Inc (SUPN) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de SUPN, ordenadas por similitud.
Análisis de estacionalidad de SUPN
Historically the probability of a positive October return for SUPN is 79.31%. November offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de SUPN
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $32.04 | $39.52 | $40.25 | +4.33% |
| Nov 2026 | $29.48 | $29.51 | $33.72 | -22.09% |
| Dec 2026 | $22.31 | $29.28 | $33.77 | -22.71% |
En 2026, se proyecta que Supernus Pharmaceuticals Inc (SUPN) oscile entre $22.31 y $40.25.
Previsión mensual de Supernus Pharmaceuticals Inc para 2026
En Oct de 2026, se proyecta que Supernus Pharmaceuticals Inc promedie $39.52, con un mínimo de $32.04 y un máximo de $40.25.
En Nov de 2026, se proyecta que Supernus Pharmaceuticals Inc promedie $29.51, con un mínimo de $29.48 y un máximo de $33.72.
En Dec de 2026, se proyecta que Supernus Pharmaceuticals Inc promedie $29.28, con un mínimo de $22.31 y un máximo de $33.77.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.